Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and cancer center visits.

Jump to a Topic:

Doctors at Duke Cancer Center

Treating Mesothelioma Cancer at Duke

Duke Comprehensive Cancer Center provides a wide range of services that include the latest in diagnostic and mesothelioma treatment advances available to patients from across the state.

The multidisciplinary team approach to care includes surgical oncologists, medical oncologists, radiation oncologists and cancer nurses who work closely together to coordinate individualized care for each patient.

Nutritionists, pharmacists, social workers, counselors and other cancer-specific caregivers also are part of the Duke Cancer Center.

Duke Is Home to Top Mesothelioma Doctors

Dr. Scott Antonia, who previously served at the Moffitt Cancer Center in Tampa, recently joined the staff as director of the new Cancer Immunotherapy Program, adding expertise to advance the treatment of thoracic malignancies.

Thoracic surgeons Dr. David Harpole Jr., vice chief of the Division of Surgical Services, and Dr. Betty Tong, thoracic and cardiovascular specialist, are authorities on pleural mesothelioma and various lung diseases.

Medical oncologists Dr. Jennifer Garst, Dr. Thomas Stinchcombe and Dr. Jeffrey Clarke specialize in thoracic disease. Radiation oncologist Dr. Christopher Kelsey sees patients with lung disease, too.

Patients have access to on-site mesothelioma clinical trials that often lead to the cutting-edge treatments. Those trials include the exploration of genomics and the advancement of gene therapy.

Serving Cancer Patients Throughout North Carolina

The Duke Cancer Center, which includes hospitals in Durham, Raleigh and Cary, North Carolina, also has a regional network of 20 community cancer programs spread across the state.

Within this network, patients have access to the same treatments, clinical trials and education programs.

Duke also holds a prestigious National Cancer Institute Comprehensive Cancer Center designation, which puts it in the top 4% of centers within the United States.

Duke has specialists that cover a wide-range of disease, including mesothelioma, prostate, kidney, liver, gynecologic, lung, breast, colon, bladder, brain, esophageal and eye cancers, among many others.

The Duke Cancer Center takes pride in bridging the gap between cancer care and research by unifying more than 300 researchers and physicians, along with 500 clinical staff members.

One of the goals at Duke is moving groundbreaking discoveries in the laboratory to the clinic, where new cancer treatments are being utilized effectively for as many patients as possible.

The Duke Cancer Center is one of America’s largest and most active research and clinical combinations. More than 6,000 new cancer patients are seen annually.

U.S. News & World Report put Duke University Hospital on its 2018-2019 Best Hospitals Top 20 Honor Roll.

Mesothelioma Clinical Trials at Duke Cancer Center

  • A randomized phase l/ll clinical trial that compares the effectiveness of Keytruda (pembrolizumab) with — and without — anetumab ravtansine in treating pleural mesothelioma.
Find Other Mesothelioma Cancer Centers

Disclaimer: Duke Cancer Center has no professional affiliation with

Stethoscope Icon
Get Help Contacting this Cancer Center

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get Free Recipes for Mesothelioma Patients

Get Your Guide Mesothelioma Packet

Get the Top Mesothelioma Guide for Free

Get Yours Now

Get the Compensation You Deserve

Find an Attorney

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at
Edited by

4 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Duke Cancer Institute. (2019, February 22). Antonia Appointed Director of DCI Center for Cancer Immunotherapy.
    Retrieved from:
  2. U.S. News & World Report. (2018, August 14). U.S. News Announces 2018-2019 Best Hospitals.
    Retrieved from:
  3. Duke Cancer Institute. (n.d.). Cancer Care as it should be.
    Retrieved from:
  4. Duke Health. (n.d.). Cancer Care. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified March 24, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now